苏塞特里金:第一次获得批准
1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
Drugs
|May 5, 2025
概括
苏丁是一种新的非阿片类止痛药,向NaV1.8通道. 它已在美国批准用于中度至严重的急性疼痛,标志着一种新的止痛药类.
科学领域:
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
- 神经科学是一个神经科学.
背景情况:
- 苏泽特里金 (JOURNAVXTM) 是一种口服的非阿片类止痛药,由Vertex Pharmaceuticals Inc.开发.
- 它对电压关闭的通道NaV1.8具有很高的选择性,这在外围疼痛信号中至关重要.
- NaV1.8通道表达在外围疼痛感应神经元中,但不在大脑中.
研究的目的:
- 总结一下suzetrigine的发展里程碑.
- 为了突出其首次批准用于治疗中度至重度急性疼痛.
主要方法:
- 开发一种选择性NaV1.8抑制剂.
- 对急性疼痛管理的临床评估.
主要成果:
- 苏三于2025年1月30日获得美国FDA批准,用于成人中度至重度急性疼痛.
- 它通过阻断外围神经元上的NaV1.8通道来起作用,从而抑制疼痛信号的传输.
- 本次批准确立了suzetrigine作为新疗法类中的第一个NaV抑制剂.
结论:
- 苏泽特里金代表了非阿片类药物止痛药的重大进步.
- 它的向机制为治疗急性疼痛提供了一种新的方法.
- 这一发展标志着疼痛管理疗法的突破.
相关概念视频
Gene Therapy
24.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
24.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


